Related references
Note: Only part of the references are listed.A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)
Wasaburo Koizumi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
Present and Future Status of Gastric Cancer Surgery
Makoto Saka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
K. R. Fareed et al.
BRITISH JOURNAL OF CANCER (2010)
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
Yasushi Sato et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
Jaffer A. Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Role of Surgery in the Treatment of Gastric Cancer
Yingqiang Shi et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Neoadjuvant Therapy of Locally Advanced Gastric Cancer
James J. Mezhir et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis
Wei Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer
T. Yoshikawa et al.
BRITISH JOURNAL OF SURGERY (2009)
Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002)
Taira Kinoshita et al.
GASTRIC CANCER (2009)
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
J. Matsubara et al.
BRITISH JOURNAL OF CANCER (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer
H. -C. Kwon et al.
ANNALS OF ONCOLOGY (2007)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: Degree of pathologic response and not clinical parameters dictated patient outcome
JA Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-Irradiation
R Takimoto et al.
CANCER BIOLOGY & THERAPY (2002)
Share Paper
